Alpha 2.0
Login Register
» Authors » Montarat Thavorncharoensap

Montarat Thavorncharoensap

Explore the profile of Montarat Thavorncharoensap including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 79
Citations 2008
Followers 0
Related Specialties
General Medicine
Public Health
Pharmacology
Top 10 Co-Authors
Usa Chaikledkaew
Sitaporn Youngkong
Arthorn Riewpaiboon
Ammarin Thakkinstian
Yot Teerawattananon
Naiyana Praditsitthikorn
Thunyarat Anothaisintawee
Jiraphun Jittikoon
Jomkwan Yothasamut
Susi Ari Kristina
Published In
Expert Rev Pharmacoecon Outcomes Res
PLoS One
Asian Pac J Cancer Prev
J Med Assoc Thai
Value Health
Affiliations
Soon will be listed here.
Recent Articles
1.
Economic evaluation of diagnostic tests for Thai patients with tuberculosis: A dynamic transmission model approach
Chitpim N, Praditsitthikorn N, White L, Meeyai A, Jittikoon J, Bunwong K, et al.
PLoS One . 2025 Mar; 20(3):e0315772. PMID: 40029874
Conventional tuberculosis (TB) diagnosis is time-consuming, while newer molecular assays such as Xpert MTB/RIF and loop-mediated amplification test for TB (TB-LAMP) provide faster results but at a higher cost compared...
2.
A comparison of health-related quality of life between continuous ambulatory peritoneal dialysis and automated peritoneal dialysis in children with stage 5 chronic kidney disease in Thailand: a randomized controlled trial
Thavorncharoensap M, Chaikledkaew U, Youngkong S, Assanatham M, Wisanuyotin S, Chaiyapak T, et al.
Pediatr Nephrol . 2025 Jan; PMID: 39833615
Background: Improving health-related quality of life (HRQoL) is one of the main goals in managing stage 5 chronic kidney disease (CKD). However, limited evidence compares HRQoL between continuous ambulatory peritoneal...
3.
Economic evaluation of tenofovir disoproxil fumarate prophylaxis to prevent mother-to-child transmission of Hepatitis B virus infection: evidence from a lower-middle income country
Nguyen H, Chaikledkaew U, Hoang M, Tran V, Thavorncharoensap M, Praditsitthikorn N, et al.
BMC Health Serv Res . 2024 Dec; 24(1):1658. PMID: 39732705
No cost-effectiveness information of preventive strategies for mother-to-child transmission (MTCT) of hepatitis B virus (HBV) has existed for policy decision making. This study aimed to compare the cost-effectiveness of alternative...
4.
Cost-utility and budget impact analysis of laparoscopic bariatric surgery for obesity with Type II Diabetes Mellitus in Thailand
Noparatayaporn P, Thavorncharoensap M, Chaikledkaew U, Looareesuwan P, Shantavasinkul P, Sumritpradit P, et al.
PLoS One . 2024 Dec; 19(12):e0315336. PMID: 39656751
Methods: A Markov model was developed to estimate and compare total costs incurred and quality-adjusted life years (QALYs) gained between bariatric surgery and nonbariatric surgery over lifetime horizontal. Analysis was...
5.
Cost Effectiveness of Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: A Systematic Review and Meta-analysis
Wattanasukchai L, Bubphan T, Thavorncharoensap M, Youngkong S, Chaikledkaew U, Thakkinstian A
Am J Cardiovasc Drugs . 2024 Nov; 25(2):169-189. PMID: 39570492
Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and is associated with substantial morbidity and mortality. Current international guidelines recommend antiarrhythmic drugs or catheter ablation (CA) as rhythm-control...
6.
Impact of the COVID-19 pandemic on time to treatment, treatment patterns and outcomes among patients with acute coronary syndrome in Yogyakarta, Indonesia: a retrospective cohort study
Dewi P, Youngkong S, Sunantiwat M, Nathisuwan S, Thavorncharoensap M
BMJ Open . 2024 Oct; 14(10):e079060. PMID: 39401963
Objective: This study aimed to evaluate the impact of the COVID-19 pandemic on the management of acute coronary syndrome (ACS) in Yogyakarta, Indonesia with respect to time to treatment, treatment...
7.
Economic evaluation of diagnosis and treatment for latent tuberculosis infection among contacts of pulmonary tuberculosis patients in Thailand
Yoopetch P, Wu O, Jittikoon J, Thavorncharoensap M, Youngkong S, Praditsitthikorn N, et al.
Sci Rep . 2024 Jul; 14(1):17693. PMID: 39085338
Currently, interferon-gamma release assay (IGRA) is costly and not included as latent tuberculosis infection (LTBI) screening test strategy in Thailand's Universal Coverage Scheme (UCS) benefit package. The objective of this...
8.
Cost-effective analysis of hepatitis A vaccination in Kerala state, India
Gurav Y, Bagepally B, Chitpim N, Sobhonslidsuk A, Gupte M, Chaikledkaew U, et al.
PLoS One . 2024 Jun; 19(6):e0306293. PMID: 38935781
Several hepatitis A outbreaks have recently been reported in Kerala state, India. To inform coverage decision of hepatitis A vaccine in Kerala, this study aimed to examine the cost-effectiveness of...
9.
Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey
Youngkong S, Kamolwat P, Wongrot P, Thavorncharoensap M, Chaikledkaew U, Nateniyom S, et al.
Sci Rep . 2024 May; 14(1):11205. PMID: 38755216
Tuberculosis (TB) causes an economic impact on the patients and their households. Although Thailand has expanded the national health benefit package for TB treatment, there was no data on out-of-pocket...
10.
Treatment seeking experiences of ACS patients in Yogyakarta, Indonesia during COVID-19 pandemic: A qualitative study
Dewi P, Sunantiwat M, Thavorncharoensap M, Youngkong S, Nathisuwan S, Rahajeng B
PLoS One . 2024 Apr; 19(4):e0302320. PMID: 38687806
Delay in treatment seeking is recognized as a major contributor for Acute Coronary Syndrome (ACS) mortality in Indonesia. Despite the significance of timely treatment, decline in admission and delay in...